CHICAGO (Reuters) – U.S. government scientists have begun efforts to create a strain of the new coronavirus that could be used in human challenge tests of vaccines, a controversial type of study in which healthy volunteers would vaccinate and then deliberately infect with the virus, Reuters has learned. FILE PHOTO: …
Read More »
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, US, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Modern Inc (MRNA.O) said there was a possibility that it was not the first company to make breakthroughs required …
Read More »
FILE PHOTO: Chinese fax manufacturer CanSino Biologics’ sign is pictured at its building in Tianjin, China November 20, 2018. REUTERS / Stringer / File Photo DUBAI (Reuters) – Saudi Arabia will soon begin Phase III clinical trials on about 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics …
Read More »
(Reuters) – Britain’s AstraZeneca (AZN.L) said Thursday that good data is being obtained so far on its vaccine against COVID-19, which is already in large-scale human trials and is widely regarded as the leader in the race for a vaccine against the new coronavirus. . An employee is seen at …
Read More »
(Reuters) – Moderna Inc (MRNA.O) said Sunday that it received an additional $ 472 million from the United States government’s Advanced Biomedical Research and Development Authority (BARDA) to support the development of its new coronavirus vaccine. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a …
Read More »